Recently released court documents highlight an audit that found the Sackler family withdrew $10.7 billion from Purdue Pharma between the 2008 to 2017 as scrutiny over the opioid epidemic and the company’s signature drug OxyContin grew.
Sacklers Withdrew Over $12 Billion From Purdue Pharma As The Opioid Epidemic Grew
